A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib. [electronic resource]
Producer: 20170127Description: 253-259 p. digitalISSN:- 1791-7530
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- pharmacology
- Antigens, Neoplasm -- metabolism
- Becaplermin
- Biomarkers, Tumor -- metabolism
- Carbonic Anhydrase IX -- metabolism
- Carcinoma, Renal Cell -- drug therapy
- Cyclin D1 -- metabolism
- Disease-Free Survival
- Female
- Humans
- Indoles -- pharmacology
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neovascularization, Pathologic -- drug therapy
- Proto-Oncogene Proteins c-sis -- metabolism
- Pyrroles -- pharmacology
- Receptors, Platelet-Derived Growth Factor -- metabolism
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Sunitinib
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.